Immediate Impact
56 standout
Citing Papers
Pancreatic cancer
2025 Standout
Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
2025 Standout
Works of Ursa Brown‐Glaberman being referenced
Updated results of a phase 1 study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC; SGNS40-001).
2023
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ursa Brown‐Glaberman | 211 | 98 | 89 | 150 | 37 | 366 | |
| Saya Jacob | 219 | 109 | 130 | 83 | 27 | 345 | |
| Aleksandra Ambicka | 177 | 75 | 101 | 137 | 31 | 368 | |
| Michał Jankowski | 118 | 60 | 98 | 119 | 43 | 348 | |
| Xinjian Huang | 162 | 64 | 106 | 177 | 25 | 356 | |
| Manuel Nietert | 125 | 109 | 27 | 105 | 31 | 379 | |
| Zhijuan Wu | 99 | 68 | 107 | 172 | 41 | 370 | |
| Marianna Sirico | 189 | 118 | 123 | 159 | 34 | 373 | |
| Cristina Bottin | 109 | 63 | 73 | 157 | 30 | 387 | |
| Cristina Cotarelo | 122 | 42 | 65 | 109 | 20 | 306 | |
| Akash Gupta | 99 | 49 | 53 | 152 | 36 | 384 |
All Works
Loading papers...